• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 62 of 100
A Rite Aid Corp. Store As Earnings Figures Are Released
RetailRite Aid Shares Fall 19% On Fear Feds Could Nix Walgreens Mega-Deal
By Phil WahbaJanuary 20, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Decline With Banks, Health Shares Lower
HealthWhy These Two Pharma Stocks Are Having Drastically Different Days
By Sy MukherjeeJanuary 20, 2017
483106863
HealthWhy Some of Big Pharma’s Best-Selling Drugs Are In Trouble This Year
By Sy MukherjeeJanuary 19, 2017
Donald Trump
HealthWhy Trump’s Plan to Keep Drug Prices in Check Would Revive ‘Death Panel’ Politics
By Sy MukherjeeJanuary 13, 2017
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthCVS Is Now Selling an EpiPen Competitor at a Massive Discount
By Sy MukherjeeJanuary 12, 2017
Businesswomen working at computer desk in office
HealthMore Than 100 Biopharma Execs Are Pushing for More Gender Diversity in the Industry
By Sy MukherjeeJanuary 11, 2017
Donald Trump
HealthBiotech Stocks Plunge After Trump Says Pharma Is ‘Getting Away With Murder’ on Drug Prices
By Sy MukherjeeJanuary 11, 2017
HealthThis Revolutionary New Tech Uses Light to Activate Medicine
By Sy MukherjeeJanuary 4, 2017
Pharmaceutical Production Inside Merck KGaA Health Care Laboratory
HealthThe Perils of Polypharmacy
By Clifton LeafJanuary 3, 2017
Daily Antiretroviral Pill Found To Protect Healthy From AIDS Transmission
Health5 Major Trends That Shaped Biopharma’s 2016
By Sy MukherjeeDecember 26, 2016
Biogen to Fire Workers, Restructure R&D After Difficult Year
LeadershipHere’s Why Investors Weren’t Excited About Biogen’s New CEO
By ReutersDecember 20, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthMylan Will Start Selling Its Generic EpiPen at a Major Discount
By ReutersDecember 16, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health20 States Are Suing Mylan and Other Drug Companies for Allegedly Fixing Prices
By Reuters and Michelle TohDecember 16, 2016
Hepatitis C drug can cure, if patients can get it
HealthMerck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By ReutersDecember 15, 2016
Vitamin and Mineral pills
HealthWhy Did New Drug Approvals in the U.S. Plunge This Year?
By Sy MukherjeeDecember 15, 2016
1...
  • 60
  • 61
  • 62
  • 63
  • 64
...100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.